Newly released whitepaper urges employers to
break down barriers to leading-edge cancer treatments
LOS
ANGELES, July 11, 2024 /PRNewswire/ -- Private
Health Management ("PHM"), a clinically sophisticated complex care
management firm, announces the release of its whitepaper, "The
Importance of Clinical Trials in Cancer Care." This report
highlights the critical role of clinical trials in advancing cancer
treatment, improving patient outcomes, and lowering costs for
employers.
Clinical trials are crucial for testing the safety and efficacy
of new medical treatments and interventions. However, access to
these trials has often been hindered by the clinical and scientific
complexity of identifying and prioritizing appropriate trials.
Other challenges impacting enrollment include geographic location,
socioeconomic status, and lack of awareness. According to recent
estimates, just 7% of patients with cancer in the U.S. have
participated in a clinical trial. PHM's trial enrollment rate is
25%, demonstrating the potential for significantly higher
participation in clinical trials when care management support is
provided.
"PHM is proud of its ability to bridge the gap between
groundbreaking medical research and the patients who may benefit
from it," said Ken Tarkoff, Chief
Executive Officer, PHM. "This whitepaper builds on our longstanding
commitment to innovation in healthcare and our collaboration with
leading physicians to provide patients with the best of what's
possible in medicine."
Whitepaper highlights include:
- Patient Access: PHM patients with cancer are nearly four times
more likely to join a clinical trial than the general population,
resulting in better access to leading edge treatment.
- Medical and Pharmacy Cost: For employers, clinical trials can
help ease the financial burden of cancer by enabling access to
treatments that are generally covered by the trial sponsor.
- Healthcare Equity: The report highlights existing inequities in
clinical trial enrollment and advocates for breaking down barriers
to ensure all patients, regardless of their background or
geography, can benefit from the latest advances in cancer
care.
"For our patients with cancer, we provide end-to-end care
management support, which includes having access to potentially
lifesaving clinical trials," said Natalya
Gertsik, PhD. "Our scientists and clinicians work closely
with our clients and their oncologists to identify, prioritize,
confirm eligibility, and manage enrollment in clinical trials, as
well as provide education and support to the patient throughout
their care journey."
PHM's commitment to patient advocacy is reflected in its
comprehensive approach to care, which combines deep clinical
expertise with personalized support. A study of PHM's cancer care
management services not only showed a nearly 4x improvement in
clinical trial enrollment but also demonstrated a two to six-fold
increase in survival rates for certain late-stage cancers and
significantly improved adoption of precision oncology.
Download "The Importance of Clinical Trials in Cancer Care".
About PHM
Private Health Management is a
clinically sophisticated complex care management company
specializing in assisting individuals in obtaining the best care
and outcomes when facing serious and complex medical conditions
like cancer. We help improve outcomes and optimize costs for
individuals and employers by delivering science-backed information
and supporting members from diagnosis through
treatment. PrivateHealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/private-health-management-advocates-for-better-use-of-clinical-trials-302195393.html
SOURCE Private Health Management, Inc.